United Therapeutics-Liquidia patent litigation

Mapped to your portfolio

Overview

Description United Therapeutics and Liquidia have settled litigation over Yutrepia, resolving pending disputes while preserving Liquidia’s access to the pulmonary-hypertension drug. Overview A Delaware court had found that Liquidia’s Yutrepia infringed patent claims asserted by United Therapeutics. United Therapeutics then sought…

Possible scenarios

45%Full Injunction Granted0.0%
25%Partial Restrictions Imposed0.0%
20%Appeal Stay Granted0.0%

For information only. Not investment advice.

Stories in this saga

1 story, 2 sources

Oct 1, 2026
Liquidia Shares Plunge After Patent Loss
- United Therapeutics Pushes to Pull Yutrepia Off Market Entirely20 days ago
- Liquidia Shares Plunge 57% on Patent Loss to United Therapeutics20 days ago

Mapped to your portfolio

Overview

Possible scenarios

Keeping an eye on this saga?

Stories in this saga

Liquidia Shares Plunge After Patent Loss

Portfolio

Possible scenarios

Mapped to your portfolio